Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids

<b><i>Background</i></b>: Selective progesterone receptor modulator ulipristal acetate (UPA) is a drug used in management of symptomatic myomas. It was observed that the response to UPA treatment in uterine myomas varied amongst patients. An attempt was thus made at establish...

Full description

Bibliographic Details
Main Authors: Iwona Szydłowska, Aleksandra Marciniak, Jolanta Nawrocka-Rutkowska, Aleksandra Rył, Andrzej Starczewski
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Environmental Research and Public Health
Subjects:
uterine myomas
ulipristal acetate
predictive factors
Online Access:https://www.mdpi.com/1660-4601/17/3/798

Similar Items

Similar Items